The HMGB1 protein induces a metabolic type of tumour cell death by blocking aerobic respiration
Citations Over TimeTop 10% of 2016 papers
Abstract
The high-mobility group box 1 (HMGB1) protein has a central role in immunological antitumour defense. Here we show that natural killer cell-derived HMGB1 directly eliminates cancer cells by triggering metabolic cell death. HMGB1 allosterically inhibits the tetrameric pyruvate kinase isoform M2, thus blocking glucose-driven aerobic respiration. This results in a rapid metabolic shift forcing cells to rely solely on glycolysis for the maintenance of energy production. Cancer cells can acquire resistance to HMGB1 by increasing glycolysis using the dimeric form of PKM2, and employing glutaminolysis. Consistently, we observe an increase in the expression of a key enzyme of glutaminolysis, malic enzyme 1, in advanced colon cancer. Moreover, pharmaceutical inhibition of glutaminolysis sensitizes tumour cells to HMGB1 providing a basis for a therapeutic strategy for treating cancer.
Related Papers
- → Pyruvate Kinase M2 and Cancer: The Role of PKM2 in Promoting Tumorigenesis(2020)488 cited
- → M2 isoform of pyruvate kinase is dispensable for tumor maintenance and growth(2012)159 cited
- → Oleanolic Acid Suppresses Aerobic Glycolysis in Cancer Cells by Switching Pyruvate Kinase Type M Isoforms(2014)71 cited
- → Pyruvate kinase M2 promotes the growth of gastric cancer cells via regulation of Bcl-xL expression at transcriptional level(2012)75 cited
- → The Emerging Role of Pyruvate Kinase M2 in Regulating Glutaminolysis via c-Myc(2021)